Diabetes & Vascular Diseases

2022 Abstracts

KSI-301 Anti-VEGF Antibody Biopolymer Conjugate for Retinal Vein Occlusion: Primary 24-Week Efficacy and Safety Outcomes of the BEACON Phase III Pivotal Study

Author: Arshad Khanani

Co-authors: Jason S Ehrlich, Daniel Janer, Pablo Velazquez-Martin, Rezi Zawadzki, Victor Perlroth

2022 Abstracts

BEHOLD Trial 12-week Data: Phase 2 Study of UBX1325, A Novel Senolytic Agent Being Studied for Patients with Advanced DME

Author: Arshad Khanani

Co-authors: Sharon Klier, Ben Xie, Lauren Masaki, Sara Huang, Jamie Dananberg

2022 Abstracts

Brolucizumab for the Treatment of Diabetic Macular Edema: 52-week Results from the KINGFISHER Study

Author: Mark Barakat

Co-authors: Rishi P. Singh, Michael Ip, Patrick M. Higgins, Veeral Sheth, David Eichenbaum, Charles Wykoff, Yong Soo Kim, Fanyin He, GaEun Cho, Yuhua Wang, Andres Emanuelli

2022 Abstracts

Deep Learning Model to Identify Moderately Severe and Severe Non-proliferative Diabetic Retinopathy From 7-Field Colour Fundus Photographs

Author: Jose Cunha-Vaz

Co-authors: Dimitrios Damopoulos, Qi Yang, Ales Neubert, Luis Mendes, Torcato Santos, Nripun Sredar, Daniela Ferrara, Fethallah Benmansour

2022 Abstracts

Effect of Finerenone on Occurrence of Vision-threatening Events in Patients with DR

Author: Justus Garweg

Co-authors: Peter Rossing, Stefan D. Anker, Takeshi Osonoi, Bertram Pitt, Sylvia E. Rosas, Luis Miguel Ruilope, Dalong Zhu, Meike Brinker, David Finis, Sergio Leal, Thomas Schmelter, George Bakris

2022 Abstracts

Safety and effectiveness of the fluocinolone acetonide intravitreal implant (ILUVIEN): 3-year results from the European IRISS registry study

Author: Ramin Khoramnia

Co-authors: Tunde Peto, Frank Koch, Simon Taylor, Joao Castro de Sousa, Lauren Hill, Clare Bailey, Usha Chakravarthy

2022 Abstracts

OCT features predicting the response of diabetic macular oedema to treatment with fluocinolone acetonide intravitreal implant

Author: Evangelos Minos

Co-authors: Hani Hasan

2022 Abstracts

Real-world outcomes of intravitreal fluocinolone acetonide implant for the treatment of recurrent and persistent diabetic macular edema in Portugal – results from the RIVER study based on baseline visual acuity

Author: Susana Penas

Co-authors: Bernardete Pessoa, Carla Teixeira, Joao Paulo Sousa, Miguel Ruao, Angelina Meireles

2022 Abstracts

3-Year Safety and Functional Outcomes in DME Patients treated with the 0.19 mg FAc Implant in the Phase IV, Prospective PALADIN Study

Author: Michael Singer

Co-authors:

2022 Abstracts

Anatomical biomarkers after dexamethasone intravitreal implant in diabetic macular edema patients according to new ESASO Classification.

Author: Almudena

Co-authors: Cristina Blanco Marchite, Francisco Lopez Martinez, Antonio Donate Tercero, Eva Gonzalez Aquino, Carlos Cava Valenciano, Santiago Perez Pascual, Sergio Copete Piqueras

2022 Abstracts